Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. decreased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 12.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 563,899 shares of the medical instruments supplier’s stock after selling 77,806 shares during the period. Rockefeller Capital Management L.P. owned about 0.97% of Merit Medical Systems worth $54,528,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. NewSquare Capital LLC bought a new stake in Merit Medical Systems during the fourth quarter valued at $32,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Merit Medical Systems during the 4th quarter valued at about $52,000. Federated Hermes Inc. grew its position in shares of Merit Medical Systems by 139.1% during the 4th quarter. Federated Hermes Inc. now owns 655 shares of the medical instruments supplier’s stock valued at $63,000 after buying an additional 381 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in Merit Medical Systems by 237.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,388 shares of the medical instruments supplier’s stock worth $134,000 after acquiring an additional 977 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in Merit Medical Systems by 14.7% in the fourth quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier’s stock worth $144,000 after acquiring an additional 191 shares during the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Merit Medical Systems

In related news, insider Brian G. Lloyd sold 25,000 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $99.50, for a total transaction of $2,487,500.00. Following the completion of the transaction, the insider now owns 38,993 shares of the company’s stock, valued at $3,879,803.50. This trade represents a 39.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Raul Jr. Parra sold 5,361 shares of Merit Medical Systems stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $103.58, for a total value of $555,292.38. Following the transaction, the chief financial officer now directly owns 24,201 shares in the company, valued at approximately $2,506,739.58. The trade was a 18.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 109,132 shares of company stock worth $11,139,521 over the last quarter. 3.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on MMSI shares. Barrington Research reaffirmed an “outperform” rating and set a $111.00 target price on shares of Merit Medical Systems in a report on Friday. JPMorgan Chase & Co. started coverage on Merit Medical Systems in a research report on Friday, March 28th. They issued an “overweight” rating and a $120.00 target price on the stock. Piper Sandler reissued an “overweight” rating and set a $116.00 price target (up previously from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Raymond James upped their price target on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 31st. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $116.00 price objective on shares of Merit Medical Systems in a research report on Wednesday. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $114.33.

Merit Medical Systems Stock Up 0.5 %

Merit Medical Systems stock opened at $92.04 on Friday. The company’s 50-day moving average price is $101.92 and its two-hundred day moving average price is $100.86. The stock has a market cap of $5.44 billion, a price-to-earnings ratio of 45.12, a PEG ratio of 2.34 and a beta of 0.85. Merit Medical Systems, Inc. has a 52 week low of $70.70 and a 52 week high of $111.45. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.